AzTrials
AzTrials

Primiparous Women With Singleton Baby at TermNCT01926314

The Effect of Postpartum Pelvic Floor Rehabilitation in Prevention and Treatment of Pelvic Floor Dysfunction

A study testing PHENIX Neuromuscular Stimulation Therapy System device and usual home care without device in people with Primiparous Women With Singleton Baby at Term, run by Peking Union Medical College Hospital at 4 sites in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Pregnancy and childbirth are considered as risk periods for injuries to the pelvic floor and development of pelvic floor dysfunction. This may leed to devastating loss of function and quality of life.The aim of this study is to evaluate the effect of postpartum pelvic floor muscle training with the device "PHENIX… Read more about this study

Who is it for?
Ages 18 to 50 years, women onlyHealthy volunteers can take part
What is being tested?
PHENIX Neuromuscular Stimulation Therapy System device and usual home care without device
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,000 participants
Where
4 sitesChina
Study dates
Aug 2013to Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • primiparous delivery
  • term delivery
  • single childbirth
  • aged from 18-50yrs

Who cannot join

  • urinary incontinence before pregnancy
  • fecal incontinence before pregnancy
  • organ prolapse before pregnancy
  • history of childbirth or induced labor with pregnancy more than 28 weeks
  • multiparity
  • newborn weight less than 2500 grams or more than 4000 grams
Show all 13Show fewer
  • precipitate labor
  • complication of pregnancy
  • asthma
  • long-term abdominal pressure(chronic cough>1 month,chronic constipation)
  • diabetes
  • sciatica
  • history of pelvic operation

Trial locations and contacts

4 sites in 1 country.

China4 sites, 4 recruiting
  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, 100730

    Lan Zhu, 86-10-69156238, zhu_julie@sina.com

    Lan Zhu

    Recruiting
  • Foshan maternal and child health hospital

    Foshan, Guangdong, 528000

    Yuling Wang, 86-13049161630, wujun701121@126.com

    Yuling Wang

    Recruiting
  • The first affiliated hospital of Guangzhou medical college

    Guangzhou, Guangdong, 510120

    Xiaowei Zhang, 86-13609086710, xwzhang81341235@163.com

    xiaowei zhang

    Recruiting
  • Wuxi Maternal and Child Health Hospital, Nanjing Medical University

    Wuxi, Jiangsu, 214002

    Jian Gong, gongjianwx@126.com

    Jian Gong

    Recruiting

Other trials in China

About this study

Official title: The Effect of Postpartum Pelvic Floor Rehabilitation in Prevention and Treatment of Pelvic Floor Dysfunction- a Multiple Centers Cooperation Research.

Pregnancy and childbirth are considered as risk periods for injuries to the pelvic floor and development of pelvic floor dysfunction. This may leed to devastating loss of function and quality of life.The aim of this study is to evaluate the effect of postpartum pelvic floor muscle training with the device "PHENIX Neuromuscular Stimulation Therapy Systems" on the recovery of pelvic floor function for primiparous women.

Being tested
PHENIX Neuromuscular Stimulation Therapy System device, usual home care without device

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PHENIX Neuromuscular Stimulation Therapy System deviceDevice

  • usual home care without deviceOther

Study groups in NCT01926314
Study groupRoleWhat they receive
deviceExperimentalPatients in this group will be offered pelvic floor muscle rehabilitation program using PHENIX Neuromuscular Stimulation Therapy System device. The participants will start therapy once a week 42 days after delivery, and last 8 weeks.
Receives: Device: PHENIX Neuromuscular Stimulation Therapy System device
usual home care without deviceActive comparatorPatients in this group will receive usual home care without device.
Receives: Other: usual home care without device

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. strength of deep muscle fiber I

    Strength of deep muscle fiber I is one of the index of electrophysiology function of pelvic floor.

    Measured: 42 days after delivery

  2. strength of deep muscle fiber I

    Strength of deep muscle fiber I is one of the index of electrophysiology function of pelvic floor.

    Measured: 6 months after delivery

  3. strength of deep muscle fiber I

    Strength of deep muscle fiber I is one of the index of electrophysiology function of pelvic floor.

    Measured: 12 months after delivery

  4. strength of deep muscle fiber II

    Strength of deep muscle fiber II is one of the index of electrophysiology function of pelvic floor.

    Measured: 42 days after delivery

  5. strength of deep muscle fiber II

    Strength of deep muscle fiber II is one of the index of electrophysiology function of pelvic floor.

    Measured: 6 months after delivery

  6. strength of deep muscle fiber II

    Strength of deep muscle fiber II is one of the index of electrophysiology function of pelvic floor.

    Measured: 12 months after delivery

  7. muscular fatigue level

    muscular fatigue level is one of the index of electrophysiology function of pelvic floor.

    Measured: 42 days after delivery

  8. muscular fatigue level

    muscular fatigue level is one of the index of electrophysiology function of pelvic floor.

    Measured: 6 months after delivery

  9. muscular fatigue level

    muscular fatigue level is one of the index of electrophysiology function of pelvic floor.

    Measured: 12 months after delivery

  10. myoelectric potential

    myoelectric potential is one of the index of electrophysiology function of pelvic floor.

    Measured: 42 days after delivery

  11. myoelectric potential

    myoelectric potential is one of the index of electrophysiology function of pelvic floor.

    Measured: 6 months after delivery

  12. myoelectric potential

    myoelectric potential is one of the index of electrophysiology function of pelvic floor.

    Measured: 12 months after delivery

  13. A3 reflex

    A3 reflex is one of the index of urinary continence function of pelvic floor.

    Measured: 42 days after delivery

  14. A3 reflex

    A3 reflex is one of the index of urinary continence function of pelvic floor.

    Measured: 6 months after delivery

  15. A3 reflex

    A3 reflex is one of the index of urinary continence function of pelvic floor.

    Measured: 12 months after delivery

  16. dynamic pressure of pelvic floor

    dynamic pressure of pelvic floor is one of the index of urinary continence function.

    Measured: 42 days after delivery

  17. dynamic pressure of pelvic floor

    dynamic pressure of pelvic floor is one of the index of urinary continence function.

    Measured: 6 months after delivery

  18. dynamic pressure of pelvic floor

    dynamic pressure of pelvic floor is one of the index of urinary continence function.

    Measured: 12 months after delivery

Secondary outcomes (6)
  1. change from baseline in PFIQ-7 scores

    Measured: 42 days after delivery

  2. change from baseline in PFIQ-7 scores

    Measured: 6 months after delivery

  3. change from baseline in PFIQ-7 scores

    Measured: 12 months after delivery

  4. in subjects sexually active at baseline, assessment of sexual function using PISQ-12

    Measured: 42 days after delivery

  5. in subjects sexually active at baseline, assessment of sexual function using PISQ-12

    Measured: 6 months after delivery

  6. in subjects sexually active at baseline, assessment of sexual function using PISQ-12

    Measured: 12 months after delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Aug 2013 (estimated)
  2. Study startAug 2013
  3. Primary completionDec 2017 (estimated)
  4. Study completionDec 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
1,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01926314
Sponsor's protocol ID
pumch-gyn-06
Status last verified
Aug 2013
First submitted
17 Aug 2013
Last updated
20 Aug 2013
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing PHENIX Neuromuscular Stimulation Therapy System device and usual home care without device in people with Primiparous Women With Singleton Baby at Term, run by Peking Union Medical College Hospital at 4 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Aug 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Lan Zhu (86-10-69156238, zhu_julie@sina.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

strength of deep muscle fiber I (time frame: 42 days after delivery). The study lists 18 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in